When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 19 Mar 2025
Last updated: 11 Aug 2022

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • fever

Other diagnostic factors

  • headache
  • dizziness
  • weakness/lethargy
  • vomiting
  • myalgia
  • non-productive cough
  • dyspnoea
  • altered mental status/reduced consciousness
  • meningism
  • seizures
  • focal neurological signs
  • tachycardia
  • hypertension

Risk factors

  • history of residence in or travel to endemic area
  • contact with known infected person
  • consumption of contaminated date palm products in endemic areas
  • contact with horses in endemic areas
  • contact with pigs in endemic areas
  • contact with bats or their secretions in endemic areas
  • diabetes
  • age >40 years
  • bioterrorism

Diagnostic investigations

1st investigations to order

  • serology
  • reverse transcription-polymerase chain reaction
  • FBC
  • LFTs
  • serum urea and electrolytes
  • clotting profiles
  • CXR
  • malaria thick and thin blood films
  • blood/urine cultures
  • cerebrospinal fluid analysis
  • cerebrospinal fluid polymerase chain reaction tests for other viral encephalitides

Investigations to consider

  • MRI brain
  • EEG
  • other serological assays
  • brain biopsy/autopsy

Treatment algorithm

Contributors

Authors

Christopher Cousins, MBChB (Hons), MRCP

Speciality Registrar in Infectious Diseases

Regional Infectious Diseases Unit

Manchester

UK

Disclosures

CC declares that he has no competing interests.

Andrew Ustianowski, MB BS, FRCP, DTM&H, PhD

Consultant in Infectious Diseases and Tropical Medicine

Regional Infectious Diseases Unit

Manchester

UK

Disclosures

AU declares that he has received speaker and/or advisory board fees for Biogen, Gilead, Janssen, Merck, Sanofi, UCB, and ViiV/GlaxoSmithKline (unrelated to henipaviruses).

Peer reviewers

Catherine Houlihan, MBChB, MRCP, PhD

Clinical lecturer

University College London

London

UK

Disclosures

CH declares that she has no competing interests.

Alice Ruth Foxwell, BSc (Hons), MSc, PhD, MAE

Adjunct

National Centre for Epidemiology and Population Health

Australian National University

Canberra

Australia

Disclosures

ARF declares that she has no competing interests.

Steffen Geis, MD, MSc

Science Programme Manager

London School of Hygiene and Tropical Medicine

Karonga Prevention Study

Chilumba

Malawi

Disclosures

SG declares that he has no competing interests.

Use of this content is subject to our disclaimer